Jared S. Hopkins
Bloomberg pharma reporter. [email protected] . Views mine. Once interviewed John Oates [email protected]
Last synced from Twitter Not synced yet
FDA Approves Fish-Oil-Derived Drug for Use Preventing Heart Attacks, Strokes
Jared S. Hopkins - WSJ 15h 1 tweets
The Food and Drug Administration expanded the approved use of Vascepa to reduce the likelihood of heart attacks and strokes in high-risk patients.
BioMarin Explores Pricing Experimental Gene Therapy at $2 Million to $3 Million
Jared S. Hopkins - WSJ 5d 1 tweets
BioMarin Pharmaceutical’s experimental gene therapy for hemophilia patients could cost between $2 million and $3 million if it is approved, which could make it the world’s most expensive drug.
3
Jared S. Hopkins BioMarin Pharmaceutical’s experimental gene therapy for hemophilia patients could cost between $2 million-$3 million if it is approved, which could make it the world’s most expensive drug 5d
Bristol’s Merger With Celgene Is Already Paying Dividends, CEO Says
Jared S. Hopkins - WSJ 7d 1 tweets
Bristol-Myers Squibb needs its recently completed $74 billion merger with Celgene to pay off quickly—and says it plans to launch six new drugs in the next two years.
Drugmakers Test New Ways to Pay for Six-Figure Treatments
Jared S. Hopkins - WSJ 8d 5 tweets
Drugmakers, facing increased resistance to high prices of many new drug therapies, are trying out new reimbursement models that depend on collecting more and better patient data.
1
Jared S. Hopkins New story: Drug companies have new ways to get paid for their expensive prescription drugs—some using patients’ digital medical records and other data to peg reimbursements to results 8d
California Looks to Launch Its Own Prescription-Drug Label
Christine Mai-Duc - WSJ 12d 5 tweets
The state would become the first in the nation to launch its own prescription-drug label under a plan proposed by Gov. Gavin Newsom that aims to use governmental purchasing power to control rising health-care costs.
2
Jared S. Hopkins Breaking: Gov. Gavin Newsom Looks to Have California Launch Its Own Generic Prescription-Drug Label, The Latest Response From States To Address Rising Healthcare Costs 12d
New Virus Discovered by Chinese Scientists Investigating Pneumonia Outbreak
Natasha Khan - WSJ 13d 7 tweets
Chinese scientists investigating a mystery illness that has sickened dozens in Central China have discovered a new strain of coronavirus, a development that will test the country’s upgraded capabilities for dealing with unfamiliar infectious...
1
Jared S. Hopkins Chinese scientists investigating a mystery illness that has sickened dozens in Central China have discovered a new strain of coronavirus via 12d
Drug developers take fresh aim at 'guided-missile' cancer drugs
U.S. 14d 4 tweets
Dozens of drugmakers are conducting human trials for a record 89 therapies that ...
1
Jared S. Hopkins Drug developers take fresh aim at 'guided-missile' cancer drugs, antibody-drug conjugates, including AstraZeneca and GlaxoSmithKline from 14d
The most important drugs approved in the past decade
Adam Feuerstein - STAT 21d 7 tweets
We dug through every drug that passed FDA muster since 2010 and identified ten that have had the biggest impact on medicine and society as a whole.
1
Jared S. Hopkins As a reporter who didn't start covering pharma until 2016, I really appreciated this great roundup of important drug approvals of last decade, from n 14d
A Genetic Test Led Seven Women in One Family to Have Major Surgery. Then The Odds Changed.
Amy Dockser Marcus - WSJ 32d 21 tweets
Two sisters, their mother and aunts showed a mutation on a BRCA gene and an elevated risk of breast and ovarian cancer. But these kinds of interpretations can be revised.
2
Jared S. Hopkins A powerful piece from about 7 women in a family who chose surgery after a genetic test related to breast cancer. Then the test results changed. 31d
Novartis to Offer World’s Most Expensive Drug for Free Via Lottery
Denise Roland - WSJ 33d 5 tweets
Swiss pharmaceutical company Novartis launched a lottery-style program to give away doses of its pricey gene therapy for free, drawing criticism from patient groups.
1
Jared S. Hopkins Novartis launches a lottery-style program to give away doses of the world’s most expensive drug for free, drawing criticism from patient groups 32d
Biogen Details Case for Controversial Alzheimer’s Drug
Joseph Walker - WSJ 46d 2 tweets
Biogen tried to make the case for why two aborted studies of its experimental Alzheimer’s disease drug support its plan to seek approval from U.S. regulators, but skeptics said they remained unconvinced that the drug is effective.
1
Jared S. Hopkins Biotech company Biogen tried Thursday to make the case for why its aborted studies for an experimental Alzheimer’s drug warrant an FDA approval, but skeptics still question if the drug is effective. the latest from 46d
U.S. Considers Easing Drug Protections to Break Logjam Over Trade Pact
Natalie Andrews, William Mauldin - WSJ 49d 4 tweets
The Trump administration is considering scaling back intellectual-property protections for big drugmakers to help win Democratic support for a new trade pact with Mexico and Canada, according to people familiar with the matter.
2
Jared S. Hopkins U.S. Considers Easing Drug Protections to Break Logjam on Trade via 49d
Novartis Deal for Heart Drug Hinges on Succeeding Where Rivals Struggle
Denise Roland - WSJ 53d 3 tweets
With a planned $9.7 billion deal, Novartis is making a high-stakes bet that the Swiss health-care giant will succeed where many have struggled: launching a new heart drug.
2
Jared S. Hopkins The $9.7 billion Novartis deal turns on a quirk of how drugs are paid for in the U.S.: Insurers have less control over drugs given in hospitals than pharmacies via 53d
Many Generic Drugs Haven’t Hit Market, Hindering Cost-Control Efforts
Jared S. Hopkins - WSJ 62d 11 tweets
Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the...
2
Jared S. Hopkins THIS STORY I WROTE ISN'T ABOUT IMPEACHMENT HEARINGS... But it's important: The FDA is approving a record number of generic drugs, but many -- more than a third since 2016 -- aren't for sale 61d
FDA Panel Backs Expanding Use of Fish-Oil Derived Drug
Betsy McKay - WSJ 67d 2 tweets
An advisory panel recommended Thursday that the U.S. Food and Drug Administration approve expanding the use of a fish-oil derived drug to reduce the likelihood of heart attacks and strokes in high-risk patients.
1
Jared S. Hopkins FDA Panel backs fish-oil derived drug to expand use to reduce risk of heart attack. Amarin Chief Executive John Thero told us “16-zip on a vote is always encouraging” w\ 67d
Bankruptcy isn’t for Sackler billionaires - The Boston Globe
BostonGlobe.com 103d 1 tweets
Purdue Pharma has asked the bankruptcy court in New York to stop all the lawsuits, not just against the company, but against the Sacklers themselves.
1
Jared S. Hopkins "Bankruptcy isn’t for billionaires," Maura Healey writes in column for . Purdue Pharma recently filed Chapter 11, and its owners, the Sacklers, are now trying to get lawsuits against them halted, too. 103d
Doctor Gets 40 Years For Illegally Prescribing More Than Half A Million Opioid Doses
NPR.org 110d 2 tweets
Dr. Joel Smithers was convicted in May of more than 800 federal counts of illegal drug distribution. He was facing life in prison and a $200 million fine. The court ordered him to pay $86,000.
1
Jared S. Hopkins Doctor in Virginia Gets 40 Years For Illegally Prescribing More Than Half A Million Opioid Doses 110d
Texas Doctor Stephen M. Hahn Is a Top Contender to Head FDA
Tom Burton - WSJ 138d 11 tweets
The radiation oncologist at M.D. Anderson Cancer Center in Houston has emerged as a top candidate to be nominated by the Trump administration to become commissioner of the Food and Drug Administration.
1
Jared S. Hopkins EXCLUSIVE: The chief of radiation oncology at the M.D. Anderson cancer center is among three leading contenders for FDA post open since April writes 138d
Purdue Pharma in Talks to Resolve Opioid Cases Through Bankruptcy
Sara Randazzo - WSJ 146d 1 tweets
OxyContin maker Purdue Pharma and its owners, the Sackler family, are in talks with state and local governments to resolve more than 2,000 opioid cases in a deal valued at between $10 billion and $12 billion.
2
Jared S. Hopkins From me n : Purdue Pharma and Sacklers in talks to resolve opioid cases through a bankruptcy deal that would direct $10B -$12B to municipalities that sued -- and that family would cede ownership 146d
Johnson & Johnson Ordered to Pay $572 Million in Oklahoma Opioid Case
Sara Randazzo - WSJ 147d 3 tweets
Johnson & Johnson must pay $572 million for contributing to an opioid-addiction crisis in Oklahoma, a judge there ruled in a closely watched trial. The company said it would appeal the judgment.
1
Jared S. Hopkins Our story on $572M verdict $JNJ was ordered to pay after a judge ruled it helped cause Oklahoma opioid crisis. J&J among companies facing thousands of lawsuits. “There’s no man­u­fac­turer that’s high-fiv­ing their lawyers af­ter to­day,” one analyst said. 147d